Haier Biomedical announces share repurchase progress

Qingdao Haier Biomedical (SSE:688139) announced the progress of its share repurchase program today, revealing that it has repurchased 524,614 shares through centralized bidding on the Shanghai Stock Exchange as of March 31, 2025. This represents 0.1650% of the company's total share capital. The repurchase occurred at prices ranging from CNY 31.78 to CNY 34.69 per share, with a total expenditure of CNY 17,467,616.72 (excluding transaction costs). This repurchase is in line with the company’s previously announced plan and relevant regulations. The company intends to use the repurchased shares for employee stock ownership plans or equity incentives.